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1. Introduction 
Aneuploidy is the presence of an abnormal number of chromosomes in cells. The gain or 
loss of a chromosome in germ cells is the most common cause of chromosomal aneuploidy. 
Trisomy 21, trisomy 18, and trisomy 13 are characterized by congenital anomalies with 
intellectual disability (ID) or short lives. Recently, mosaic variegated aneuploidy (the 
presence of a different number of chromosomes in some cells) has been reported to be 
associated with ID and growth retardation, with or without microcephaly and tumors. In 
the cell cycle, the alignment of sister chromatids at metaphase plates is essential for the 
equational separation of chromatids. Misaligned chromosomes at metaphase plates, and/or 
aberration of the mitotic checkpoint, cause a disproportionate separation of chromatids, 
resulting in aneuploidy. To evaluate the association between aneuploidy and ID, we 
analyzed the chromosome numbers of over 200 metaphase plates of lymphoblastoid cells in 
patients with moderate or severe ID, with or without microcephaly. In this chapter, we 
summarize the previously reported cases and our own cases of patients with ID associated 
with aneuploidy or severely misaligned chromosomes at metaphase, and discuss the 
molecular mechanism underlying ID in cases in which aneuploidy is observed.  
2. Aneuploidy 
The most common forms of chromosomal (complete) aneuploidy are trisomy and 
monosomy. Trisomy refers to having an extra whole chromosome, and monosomy is the 
lack of 1 chromosome from a pair of chromosomes. Partial monosomy and partial trisomy, 
i.e., loss or gain of part of a chromosome, respectively, have preferentially been used instead 
of partial aneuploidy. Mosaic aneuploidy is the condition in which aneuploidy is detected in 
a fraction of cells in an individual.  
2.1 Trisomy 
Trisomy 21, also known as Down syndrome, is the most common chromosomal aneuploidy 
and a cause of ID. Down syndrome affects up to 1 in 1,000 live births (International 
Clearinghouse for Birth Defects Monitoring Systems, 1991). Down syndrome is caused by a 
www.intechopen.com
 
Aneuploidy in Health and Disease 
 
108 
failure in the proper segregation of chromosome 21 during meiosis. This chromosome 21 
nondisjunction is mostly due to maternal meiotic errors; the majority of these errors occur 
during meiosis I (~80%) (Antonarakis, 1991; Yoon et al., 1996). A recent study has suggested 
that pericentromeric exchange at meiosis II initiates or exacerbates the susceptibility to the 
risk of increased maternal age (Oliver et al., 2008). The Down syndrome critical region 
(DSCR) of human chromosome 21q22 was defined on the basis of analysis of familial cases 
of partial trisomy 21 (Korenberg et al., 1994; Ronan et al., 2007). One strategy for identifying 
the genes responsible for ID in Down syndrome is to analyze the genes located in the DSCR. 
Analyses of 2 unrelated patients with a de novo balanced translocation and a patient with a 
microdeletion within the DSCR demonstrated that DYRK1A, encoding the dual-specificity 
tyrosine phosphorylation-regulated kinase 1A, plays a critical role in brain development 
(Møller et al., 2008; Yamamoto et al., 2011). Therefore, the dosage of DYRK1A is quite 
important for brain development, and it could be one of the causative genes for ID in 
Down syndrome. Several studies demonstrated that a normal dosage of DYRK1A is 
critical for normal brain development and function. Transgenic mice overexpressing 
Dyrk1A show marked cognitive deficits and impairment in hippocampal-dependent 
memory tasks and the generation of both amyloid and tau pathologies, which are 
observed in early onset Alzheimer disease and Down syndrome (Altafaj et al., 2001; Ahn 
et al., 2006; Kimura et al., 2007; Park et al., 2007; Ryoo et al., 2008). A recent study showed 
that Dyrk1A directly interacts with and phosphorylates the regulator of calcineurin 1 
(RCAN1) protein at Ser112 and Thr192. RCAN1 is also located in the DSCR. The 
phosphorylation of RCAN1 enhances RCAN1 binding to calcineurin, resulting in reduced 
NFAT transcriptional activity. This activity is important for the outgrowth of embryonic 
axons (Graef et al., 2003; Jung et al., 2011). Thus, the increased expression of Dyrk1A 
caused by trisomy may cause impaired axon outgrowth during brain development, which 
may in turn cause ID in Down syndrome.  
Other types of common aneuploidy include trisomy 18 (Edwards syndrome), which affects 1 
in 6,000 births, and trisomy 13 (Patau syndrome), which affects 1 in 10,000 births. A recent 
study of the natural outcome of trisomy 13 and trisomy 18 after prenatal diagnosis indicates 
that the live birth rate is 13% for trisomy 18 and 33% for trisomy 13. Three of 4 live-born 
infants with trisomy 13 and all 3 trisomy 18 infants died early, within a maximum of 87 
postpartum hours. Thus, trisomy 13 and trisomy 18 are associated with a high rate of 
spontaneous abortion, intrauterine death, and a short life-span (Lakovschek et al., 2011). ID 
is not clear in these patients because of their short lives. 
2.2 Partial aneuploidy (partial monosomy and partial trisomy) 
Quite a few reports exist on patients with ID harboring chromosomal microdeletions. This 
indicates that haploinsufficiency of a gene or genes located in the deletion region are 
associated with ID. Mutational analysis of the genes located in the deletion region leads the 
identification of the causal gene(s) of ID, with or without congenital anomalies. Duplications 
of some chromosomal segments are reported to be associated with ID (1q21.1, Brunetti-
Pierri et al., 2008; 3q29, Goobie et al., 2008; Lisi et al., 2008; 16p13.11, Hannes et al., 2009; 
Xq28, Van Esch et al., 2005). This indicates that increased gene dosage(s) are associated with 
ID. It is noted that the clinical features of deletions or duplications at the same chromosomal 
segments are different. There is a tendency for duplications to show milder clinical features 
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than deletions, and autistic features more frequently appear in duplications (Table 1) 
(Marshall et al., 2008; Sebat et al., 2007).      
 
Chromosomal References
location ID Syndrome ID Clinical features
5q35 +, ++ Sotos + Microcephaly (1)
7q11.2 + Williams-Beuren +  Speech delay (2)
15q11.2 +/+++ Prader-Will/Angelman ++  Autism (3)
16p13.3 +++ Rubinstein-Taybi ++ Speech delay (4)
17p11.2 ++ Smith-Magenis ++  ADHD, Autism (3) (5)
22q11.2 ±, + DiGeorge —, ±  ADHD, Autism (6)
Deletion Duplication
 
Table 1. Clinical features of duplication or deletion at the same chromosomal region. ID, 
intellectual disability; –, absent; ±, very mild; +, mild; ++, moderate; +++, severe; ADHD, 
Attention Deficit Hyperactivity Disorder. References: (1) Hunter et al., 2005; (2) Somerville 
et al., 2005; (3) Keller et al., 2003; (4) Marangi et al., 2008; (5) Potocki et al., 2000; (6) 
Mukaddes & Herguner, 2007. 
2.3 Monosomy 
Monosomy is most commonly lethal during prenatal development. X-chromosome 
monosomy (Turner syndrome) is a commonly observed monosomy that develops without 
obvious, or with very mild, ID.  
2.4 Mosaic aneuploidy 
The most common use of the term “mosaic aneuploidy” refers to the condition in which 
aneuploidy is detected in a fraction of cells, usually in lymphocytes (lymphoblastoid cells), 
in an individual. Mosaic aneuploidy is observed in 2%–4% of Down syndrome cases, in 
which 2 types of karyotypes (trisomy 21 and normal) are present (Mikkelsen et al., 1976). In 
general, individuals who are mosaic for chromosomal aneuploidy tend to have less severe 
clinical features than those with full trisomy. Therefore, only mosaic patients may survive in 
many of the chromosomal trisomies.  
2.5 Mosaic variegated aneuploidy 
Hsu et al. (1970) reported 3 children with sex chromosome mosaicism born to 
consanguineous parents. The authors suggested that a recessive gene causing mitotic 
instability is associated with the mosaicism. Tolmie et al. (1988) and Papi et al. (1989) 
reported male and female siblings with ID, growth retardation, microcephaly, and multiple 
chromosome mosaicism involving mainly chromosome 18 or chromosomes 7 and 8, 
respectively. These findings indicate that mutations of autosomal recessive genes are 
associated with aberrant mitosis causing the observed phenotype. The term “mosaic 
variegated aneuploidy” (MVA) has been suggested to apply to patients with ID, 
microcephaly, and the above-mentioned cytogenetic findings (Warburton et al., 1991). 
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Callier et al. (2005) summarized 28 previously reported cases of MVA and showed that 26 of 
28 patients (93%) had microcephaly and 21 of 28 patients (75%) had ID, and in 2 of the 28 
cases, clinical features were not described. MVA with premature chromatid separation 
(PCS) (also called PCS syndrome; Kajii et al., 2001) has been reported (Plaja et al., 2001). 
Patients with this condition exhibit ID, intrauterine growth retardation, microcephaly, and a 
characteristic facial appearance; the syndrome is often accompanied by malignancies (Wilms 
tumor, rhabdomyosarcoma, and acute leukemia). These patients have a variety of aneuploid 
cells (~40%), but PCS is more apparent (>50%) in these cells. It is noted that healthy parents 
of patients with MVA with PCS also have PCS (~10%–40%) in their lymphocytes (Kajii et al., 
2001). Plaja et al. (2001) summarized 11 previously reported cases of MVA with PCS and 
showed that all 11 patients (100%) had microcephaly and 8 of 11 patients (73%) had ID, and 
in 2 of the 11 cases, the ID status was unknown. However, not all patients with MVA have 
microcephaly (Callier et al., 2005). 
A causative gene of MVA, the BUB1B gene encoding BUBR1, has been identified in 5 
families with MVA, including 2 with embryonal rhabdomyosarcoma (Hanks et al., 2004). 
These patients have truncating or missense mutations in both alleles of BUB1B. BUBR1 is a 
key protein in the mitotic checkpoint, and its deficiency causes aneuploidy and cancer 
development. BUB1B mutations were also identified in the patients from 7 Japanese families 
exhibiting MVA with PCS (Matsuura et al., 2006). Eight patients in the 7 families presented 
with intrauterine growth retardation, microcephaly, and a Dandy-Walker complex. Wilms 
tumor was also observed, except in 1 patient. Each patient had a loss-of-function mutation 
of BUB1B in one allele; the other allele exhibited a haplotype associated with decreased 
expression levels of BUBR1 protein. Therefore, a decrease of <50% in BUBR1 function at the 
mitotic checkpoint is associated with MVA with PCS. Recently, biallelic loss-of-function 
mutations in CEP57 were identified in 4 patients with MVA (Snape et al., 2011). All the 
patients showed random gains and losses of chromosomes in ~25%–50% of the examined 
cells. It is noteworthy that 2 patients did not have ID and microcephaly, and none had 
malignancies. The Online Mendelian Inheritance in Man (OMIM) database defines mosaic 
variegated aneuploidy syndrome 1 (MVA1) (MIM: 257300) as a syndrome caused by 
homozygous or compound heterozygous mutations in BUB1B on chromosome 15q15, and 
MVA2 (MIM: 614114) as a syndrome caused by homozygous or compound heterozygous 
mutations in CEP57 on chromosome 11q21. The proportion of aneuploid cells in MVA is 
usually >25% (Hanks et al., 2004).  
Mitotic checkpoint: The mitotic checkpoint works to ensure accurate chromosome 
segregation to avoid aneuploidy by regulating the progression from metaphase to anaphase. 
The checkpoint arrests cells in mitosis, until all chromosomes have aligned at the metaphase 
plate. Chromosome alignment depends on the attachment of microtubules emanating from 
the spindle poles to the kinetochores on chromosomes. Once the checkpoint has been 
satisfied (switched off), the cell proceeds into anaphase and completes the cell cycle (Chan et 
al., 2005; Musacchio & Salmon, 2007).  
3. Microcephaly 
Microcephaly is the most common clinical feature (developing in ~1% of the population, 
Lizarraga et al., 2010) and is usually associated with ID. Microcephaly is defined in persons 
who have a head circumference (HC) (or occipitofrontal circumference [OFC]) more than 2 
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standard deviations (-2SD) below the average circumference for the individual’s age, sex, 
race, and period of gestation.  
The size of the mammalian neocortex is determined largely by the number of neurons 
generated at the ventricular zone (VZ) during embryonic neurogenesis. Thus, defects in 
embryonic neurogenesis decrease the number of neurons in the neocortex, leading to 
microcephaly and ID. The VZ comprises progenitor cells (mainly radial glial cells); these 
progenitor cells divide symmetrically to amplify their own cell population before the peak 
phase of neurogenesis (embryonic days 13–18 in mice). During the peak phase of 
neurogenesis, progenitor cells divide into a progenitor cell and a neuron, or an intermediate 
progenitor cell (IPC), by asymmetric division. IPCs continue additional division to generate 
neurons that migrate into the cortical plate and finally form the cerebral cortex. The term 
“asymmetric” is used to refer to the generation of either different types of progenitor cells or 
division (Chenn & McConnell, 1995). A recent study has indicated that asymmetric 
inheritance of daughter and mother centrosomes regulates the differential behaviors of 
renewing progenitors and their differentiating progeny (Wang et al., 2009). Therefore, this 
finding suggests that the centrosomes play essential roles in progenitor cleavage, 
differentiation, and migration (Higginbotham & Gleeson, 2007).  
Centrosome: The centrosome is the microtubule-organizing center responsible for the 
nucleation and organization of cytoplasmic organelles, primary cilia, and mitotic spindle 
microtubules. It is located in the cell cytoplasm and contains 2 orthogonally arranged 
centrioles; each centriole has a barrel-shaped microtubule structure and is surrounded by 
pericentriolar material (PCM).  
3.1 Autosomal recessive microcephaly 
Autosomal recessive primary microcephaly (MCPH) is a neurodevelopmental disorder 
characterized by microcephaly at birth and nonprogressive ID. Its incidence is ~1 in 10,000 
in consanguineous populations. The current clinical definition of MCPH is as follows:  
(1) congenital microcephaly with an HC at least 4SD below age and sex means; (2) ID, but  
no other neurological findings; and (3) mostly normal height, weight, facial appearance, 
chromosomal analysis, and brain structure as evaluated by brain MRI (CT) (Woods  
et al., 2005).  
At least 8 MCPH loci exist, and the genes underlying 7 of these have been identified 
(MCPH1-MCPH1, MIM 251200; MCPH2-WDR62, MIM 613583; MCPH3-CDK5RAP2, MIM 
608201; MCPH4-CEP152, MIM 613529; MCPH5-ASPM, MIM 605481; MCPH6-CENPJ, MIM 
609279; and MCPH7-STIL, MIM 181590). The proteins encoding the causative genes of 
MCPH are specifically localized at the centrosome during a specific period of the cell cycle 
(Kumar et al., 2009). Therefore, the failure of proteins associated with the function and/or 
the structure (maturation) of the centrosome causes MCPH and aneuploidy. Hertwig’s 
anemia (an) mutant (Cdk5rap2an/an) mice, a mouse model of MCPH3, show reduced 
neuronal numbers and thinner superficial layers, but preserved cortical layer organization. 
These mice have a high level of aneuploidy in tissues, and neuronal progenitor cells exhibit 
mitotic defects with abnormal mitotic spindle pole number and mitotic spindle orientation. 
The abnormal number of centrosomes might produce abnormal mitosis and aneuploidy that 
would result in either cell death or cell cycle arrest in cortical progenitor cells (Lizarraga et 
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al., 2010). Taken together, neuronal progenitor cell death, accompanying abnormal mitotic 
defects and aneuploidy, could be the cause of ID in some types of MCPH. The decreased 
brain size in MCPH, without a major effect on the cortical layer structure, suggests that the 
causative genes of MCPH affect the symmetric division of progenitor cells, rather than 
asymmetric divisions associated with cortical layer formation and subsequent impaired cell 
functions or apoptosis. 
Deficiencies of those proteins (genes) that are reported to be associated with mitotic defects 
and/or aneuploidy are listed in Table 2. 
Mitotic defect: Mitotic defects include disrupted centrosomes, misaligned chromosomes, 
and spindle misorientation (spindle poles in different focal planes) at metaphase, which 
result in aneuploidy, lagging chromosomes, and anaphase bridges in dividing cells. 
 
Cellular location
Gene at metaphase Misaligned chromosomes Aneuploidy Clinical features References
BUB1B Kinetochore ++ ++ GR, Microcephaly,    (1) (2)
ID, Cancer 
CEP57 Centrosome ++ ++ GR, Microcephaly, ID (3)
 CDK5RAP2 (Cdk5rap2) Centrosome + + MCPH3, ID     (4) (5)
 CENP J Centrosome + ND MCPH6, ID     (4) (6)
 STIL Pericentrosome + ND MCPH7, ID (7)
 UBE3A Centrosome + ND Angelman syndrome, ID (8)
 NDE1 Centrosome + ND Microlissencephaly, ID (9)
ASAP Centrosome + ND ND (10) (11)
Mitotic spindle
 CHD6 Diffuse localization + + ID (12)
 PCNT Pericentrosome ND + MOPD II (13)
Deficiency of the gene
 
Table 2. Deficiencies of genes reported to be associated with misaligned chromosomes 
and/or aneuploidy. +, moderate; ++, severe; ND, not described; ID, intellectual disability; 
GR, growth retardation. References: (1) Hanks et al., 2004; (2) Matsuura et al., 2006; (3) 
Snape et al., 2011; (4) Bond et al., 2005; (5) Lizarraga et al., 2010; (6) Cho et al., 2006; (7) Pfaff 
et al., 2007; (8) Singhmar & Kumar, 2011; (9) Alkuraya et al., 2011; (10) Saffin et al., 2005; (11) 
Eot-Houllier et al., 2010; (12) Yamada et al., 2010; (13) Rauch et al., 2008. 
4. Characterization of aneuploidy in patients with moderate and severe ID 
Patients with microcephaly often present with ID, but its etiology is primarily unknown. As 
described above, recent studies have demonstrated that mitotic dysfunctions in the cell cycle 
are tightly associated with MCPHs. Although detailed data of aneuploidy in each MCPH are 
not available, aneuploidy could be found in some types of microcephaly with ID. We analyzed 
aneuploidy in 10 patients with moderate and severe ID, including 5 solitary cases with 
microcephaly (HC more than 3SD smaller than the mean) (Table 3). The number of cells 
exhibiting aneuploidy was determined by counting chromosome numbers in over 200 
metaphases derived from lymphoblastoid cells from 5 normal control subjects and 10 patients 
with ID. Two patients (Lesch-Nyhan syndrome and Rett syndrome) with ID had the same 
ratio of aneuploidy as normal controls (5%–7%). In contrast, in 3 patients with microcephaly 
www.intechopen.com
 
Aneuploidy and Intellectual Disability 
 
113 
(S1, S2, and S5), the ratio of aneuploidy increased 2–3 times (13%–21%) as compared with the 
ratio of aneuploidy in normal controls. This result indicates that there are 2 types of 
microcephaly with ID, i.e., that with and that without an increased ratio of aneuploidy in 
lymphoblastoid cells. The findings of the 3 patients with microcephaly and relatively high 
rates of aneuploidy suggest that these patients have mutations associated with mitotic defects, 
and the other 2 patients with microcephaly may have other etiologies underlying their ID that 
are not directly associated with mitotic defects of the cells and aneuploidy.  
An increased rate of aneuploidy was also identified in a patient with chromodomain 
helicase DNA (CHD)-6 haploinsufficiency (S6) and in 2 patients with CHARGE syndrome 
(manifestations are coloboma of the eye [C], heart anomalies [H], choanal atresia [A], 
retardation of mental and somatic development [R], genital anomalies [G], and ear 
abnormalities and/or deafness [E]) caused by haploinsufficiency of CHD7 (S7 and S8), 
although they did not have microcephaly (Table 3) (Yamada et al., 2010). Both proteins are 
ATP-dependent chromatin-remodeling enzymes and play important roles in maintaining 
and regulating chromatin structure. Lymphoblastoid cells from the patients with CHD6 or 
CHD7 haploinsufficiency, and CHD6 or CHD7 knockdown HeLa cells, display aneuploidy 
and an increased frequency of misaligned chromosomes, respectively (Fig. 1, Table 3) 
(Yamada et al., 2010). CHD6 associates with many proteins to form a large protein complex 
(>2 MDa) (Lutz et al., 2006). This finding and the diffused distribution of CHD6 at 
metaphase (Yamada et al., 2010) suggest that the protein complex may act as a basis for the 
formation and/or stabilization of the mitotic spindle structure.  
 
                                Aligned                                      Misaligned 
 
Fig. 1. Misaligned chromosomes observed in RNA interference (RNAi)-mediated 
knockdown of CHD6 in metaphase HeLa cells. Aligned chromosomes (left panels, control) 
and 2 types of misaligned chromosomes—with bipolar centrosomes (middle panels) and 
with 3 centrosomes (right panels)—caused by knockdown of CHD6 at metaphase are 
presented. Cells were fixed and stained with anti-alpha-tubulin (red) and anti-gamma-
tubulin (green) antibodies. Chromosomes were stained with 4′,6-diamidino-2-phenylindole 
(DAPI; blue) (upper panels). Lower panels show merged images.  
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The cytogenetic examination of the chromosomes of patients with ID (Table 3) thus gives us 
important information as to whether the patients exhibit aneuploidy. Several studies have 
demonstrated that a high level of aneuploidy (~50%) is a constant feature of human neurons 
under healthy conditions (Pack et al., 2005; Rehen et al., 2005; Yurov et al., 2005). Moreover, 
approximately 33% of neural progenitor cells display genetic variability, which is 
manifested as chromosomal aneuploidy (Kaushal et al., 2003; McConnell et al., 2004; Rehen 
et al., 2001; Yang et al., 2003). These findings indicate that the brain is a specific region for 
displaying much aneuploidy caused by genetic variability. We studied the aneuploidy of 
lymphoblastoid cells and identified increased aneuploidy in some patients with ID. 
However, it is not clear how increased aneuploidy in lymphoblastoid cells caused by the 
mutation affect the apoptosis or fate of neuronal progenitor cells. Patients with MVA and 
MVA with PCS have been shown to have a high incidence of ID (>73%) with increasing 
aneuploidy (>25%). Such increasing aneuploidy, caused by mutations, adds to the total 
aneuploidy in the neuronal progenitor cells and may cause the number of aneuploid cells to 
exceed critical thresholds for ID that is caused by the neuronal death or impaired functions 
of the progenitor cells. Therefore, it is critical to analyze the aneuploidy of neural progenitor 
cells in animal models of human diseases known to cause aneuploidy and ID. This study 
could clarify the relationship of ID and aneuploidy. To perform this kind of study, it is 
important to accumulate aneuploidy data from patients with ID, with or without 
microcephaly.  
 
ID Microcephaly Others Total metaphase  Aneuploidy PCS
(HC, at age) <46 46 47 >47 numbers (%) (%)
C1 — — Healthy control 21 277 1 1 300 7.7 ND
C2 — — Healthy control 14 283 2 1 300 5.7 ND
C3 — — Healthy control 20 278 1 1 300 7.3 ND
C4 — — Healthy control 14 281 4 1 300 6.3 1.0
C5 — — Healthy control 7 188 3 2 200 6.0 1.0
S1 ++  -4SD (2y2m) Epilepsy 21 173 6 0 200 13.5 ND
S2 ++ -3.5SD (3y0m) Epilepsy 20 170 9 1 200 15.0 ND
S3 ++ -7SD (2y4m) Polydactyly, Epilepsy 12 188 0 0 200 6.0 ND
S4 ++ -6SD (1y8m) Cerebellopontine hypoplasia 10 185 5 0 200 7.5 5.5
S5 ++ -4.3SD (2y5m) West syndrome 33 158 7 2 200 21.0 0.5
S6 ++ — CHD6 deficiency 56 329 11 4 400 17.8 —
S7 ++ — CHARGE syndrome, GR 50 333 11 6 400 16.8 —
S8 ++ — CHARGE syndrome, GR 47 338 14 1 400 15.5 1.0
S9 + — Lesch-Nyhan syndrome 9 186 4 1 200 7.0 2.0
S10 ++ — Rett syndrome 6 190 3 1 200 5.0 —
Chromosome numbers
 
Table 3. Chromosome numbers in lymphoblastoid cells from healthy control subjects 
and patients with moderate and severe ID. ID, intellectual disability; y, year; m, month;  
ND, not determined; –, absent; +, moderate; ++, severe; HC, head circumference; GR, 
growth retardation.  
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5. Conclusion  
The amplification of centrosome number and aneuploidy are frequently observed in cancer 
cells, which may reflect tumorigenesis (Fang & Zhang, 2011). Mitotic defects underlying 
misaligned chromosomes and/or aneuploidy have also been reported in some patients with 
ID. Patients with MVA and some types of microcephaly belong to this category. During 
embryonic neurogenesis, symmetrical and asymmetrical divisions of the progenitor cells are 
critically important. Impairment of neurogenesis caused by mitotic defects, such as 
abnormal functioning of centrosomes and/or spindle structures, could result in neuronal 
loss, with or without abnormal cortical layer formation. Therefore, the study of aneuploidy 
is important not only for diagnosing mitotic defects but also for analyzing the etiology of 
patients with ID. 
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